For immediate release |
4 April 2011 |
Futura Medical plc
("Futura" or "the Company")
Director's Dealings
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, has received notification that Charlotte Barder, the wife of the Chief Executive of the Company, James Barder, has today gifted in aggregate 17,500 ordinary shares in the Company to their children.
Mr Barder's beneficial holding in Futura remains unchanged. However for the purposes of the AIM Rules his aggregate beneficial and non-beneficial holdings (which include those of his wife) are thereby reduced by the amount of the gift to 727,712 ordinary shares, representing 1.00% of the Company's share capital.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive
|
Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com |
|
|
|
Nomura Code Securities Limited |
|
Phil Walker / Giles Balleny |
Tel:+44 (0)20 7776 1200 |
|
|
For media enquiries please contact: |
|
|
|
Buchanan Communications |
|
Mark Court / Jessica Fontaine |
Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.